Clinical Trials Logo

Clinical Trial Summary

This study is single center, subject will receive a wireless TENS device. All subjects will be allowed to keep the commercially-available device for use after the study. The primary goal is to test the feasibility of the study design and secondary is to test the preliminary efficacy of the TENS.


Clinical Trial Description

This study is single center, subject will receive a wireless TENS device. The coordinator will introduce the study device, be available to answer questions about the device, and assess adverse events. Subjects will be told that we are testing whether TENS, which has shown promise in some patients but needs to be tested formally, has an effects on lower limb swelling . The treatment period will be 3 weeks in duration. After the treatment period, all subjects will be asked to complete the Treatment-period Endpoint-Qualitative interview. All subjects will be allowed to keep the commercially-available device for use after the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04680533
Study type Interventional
Source University of Rochester
Contact
Status Active, not recruiting
Phase Phase 1/Phase 2
Start date June 28, 2021
Completion date September 1, 2025

See also
  Status Clinical Trial Phase
Terminated NCT00305331 - Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease Phase 2
Completed NCT00143793 - NT-proBNP and New Biomarkers in Patients With Dyspnea and/or Peripheral Edema